# Desvenlafaxine

NDC: 0054-0400
Generic name: Desvenlafaxine
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20170301

FDA application: ANDA204083

## Active ingredients

- DESVENLAFAXINE SUCCINATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0400"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0400
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=662890ff-d254-40e0-a9fe-f07ab94d65d6
